Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fraction

AIMS: Ivabradine and sacubitril/valsartan are second‐line therapies for patients with heart failure and reduced ejection fraction (HFrEF) based on guideline recommendations. We aimed to evaluate the synergistic effects of these two medications. METHODS AND RESULTS: Patients' data were extracted...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:ESC Heart Fail
Asıl Yazarlar: Lee, Ying‐Hsiang, Lin, Po‐Lin, Chiou, Wei‐Ru, Huang, Jin‐Long, Lin, Wen‐Yu, Liao, Chia‐Te, Chung, Fa‐Po, Liang, Huai‐Wen, Hsu, Chien‐Yi, Chang, Hung‐Yu
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2021
Konular:
Original Research Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8006660/
https://ncbi.nlm.nih.gov/pubmed/33410280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13182
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller